Activin and Inhibin

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase , with a K i of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phaseForm:OilIC50&amp:

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase , with a K i of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phaseForm:OilIC50&amp:

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase , with a K i of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phaseForm:OilIC50&amp:

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase , with a K i of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phaseForm:OilIC50&amp:

CDC25B-IN-1 (compound 4a) is a potent inhibitor of cell division cycle 25B (CDC25B) phosphatase , with a K i of 8.5 μM. CDC25B-IN-1 potently inhibits cell proliferation and colony formation, causes an increase of the G2/M phaseIC50&amp: Target:Ki:

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid.

CDC25B-IN-2 is a potent cdc25B inhibitor.In VitroCDC25B-IN-2 (compound 27: 20 μg/mL) has cdc25B enzyme inhibitory activities 16.11% in vitro. MCE has not independently confirmed the accuracy of these methods. They are for reference only.